Joshua Riggs
2023
In 2023, Joshua Riggs earned a total compensation of $724.9K as President and Chief Executive Officer at Oncocyte Corp, a 41% increase compared to previous year.
Compensation breakdown
| Bonus | $117,000 |
|---|---|
| Option Awards | $220,284 |
| Salary | $339,846 |
| Other | $47,780 |
| Total | $724,910 |
Riggs received $339.8K in salary, accounting for 47% of the total pay in 2023.
Riggs also received $117K in bonus, $220.3K in option awards and $47.8K in other compensation.
Rankings
In 2023, Joshua Riggs' compensation ranked 1,570th out of 2,983 executives tracked by ExecPay. In other words, Riggs earned more than 47.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,570 out of 2,983 | 47th |
Division Manufacturing | 919 out of 1,637 | 44th |
Major group Chemicals And Allied Products | 591 out of 906 | 35th |
Industry group Drugs | 575 out of 869 | 34th |
Industry In Vitro and In Vivo Diagnostic Substances | 2 out of 14 | 86th |
Source: SEC filing on April 29, 2024.
Riggs' colleagues
We found three more compensation records of executives who worked with Joshua Riggs at Oncocyte Corp in 2023.